Literature DB >> 27033872

High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: a report of four cases.

Yulan Shi1,2, Yanqin Huang3, Meiqi Zhou1,2, Xiao Ying1,2, Xiaoye Hu4,5.   

Abstract

Desmoid tumors are rare clonal fibroblastic proliferations that can arise at abdominal or extra-abdominal sites. Complete surgical resection is the primary treatment for resectable desmoid tumors, but a high rate of local recurrence has been reported even after complete resection. For patients with a recurrent tumor, the goals of treatment are to control the recurrence, maintain quality of life, and prolong survival. Radiofrequency ablation, radiotherapy, chemotherapy, and other medical therapies can be used as alternative methods, but there are considerable controversies over the roles of these methods in the management of desmoid tumors. High-intensity focused ultrasound (HIFU) is a minimally invasive and effective method for treatment of solid tumors. We used HIFU to treat four patients with intra-abdominal desmoid tumors from June 2011 to September 2013. Post-procedural pain was seen in all patients. One patient had an intra-abdominal abscess and another suffered a slight injury to the femoral nerve. The patients were followed up for 19-46 months (mean 34 months) until April 2015. The tumor in one patient disappeared, and no tumor progression was observed in the other patients.

Entities:  

Keywords:  Aggressive fibromatosis; Desmoid tumor; Desmoid-type fibromatosis; HIFU

Mesh:

Year:  2015        PMID: 27033872     DOI: 10.1007/s10396-015-0682-9

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  17 in total

Review 1.  High intensity focused ultrasound: past, present and future.

Authors:  Gail Ter Haar; Constantin Coussios
Journal:  Int J Hyperthermia       Date:  2007-03       Impact factor: 3.914

2.  Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.

Authors:  Atsushi Sofuni; Fuminori Moriyasu; Takatomo Sano; Fumihide Itokawa; Takayoshi Tsuchiya; Toshio Kurihara; Kentaro Ishii; Syujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Junko Umeda; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Mitsuru Fujita; Takao Itoi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 3.  Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.

Authors:  J J Nuyttens; P F Rust; C R Thomas; A T Turrisi
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).

Authors:  Veridiana Pires de Camargo; Mary L Keohan; David R D'Adamo; Cristina R Antonescu; Murray F Brennan; Samuel Singer; Linda S Ahn; Robert G Maki
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

5.  Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: preliminary results.

Authors:  Yang Wang; Wei Wang; Jie Tang
Journal:  Int J Hyperthermia       Date:  2011-07-28       Impact factor: 3.914

6.  Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.

Authors:  A Gronchi; P G Casali; L Mariani; S Lo Vullo; M Colecchia; L Lozza; R Bertulli; M Fiore; P Olmi; M Santinami; J Rosai
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

7.  A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

Authors:  E Stoeckle; J M Coindre; M Longy; M Bui Nguyen Binh; G Kantor; M Kind; C Tunon de Lara; A Avril; F Bonichon; B Nguyen Bui
Journal:  Eur J Surg Oncol       Date:  2008-08-29       Impact factor: 4.424

8.  Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

Authors:  Matthew P Goetz; Matthew R Callstrom; J William Charboneau; Michael A Farrell; Timothy P Maus; Timothy J Welch; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Ivy A Petersen; Robert A Beres; Daniele Regge; Rodolfo Capanna; Mark B Saker; Dietrich H W Grönemeyer; Athour Gevargez; Kamran Ahrar; Michael A Choti; Thierry J de Baere; Joseph Rubin
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

9.  Radiofrequency ablation: another treatment option for local control of desmoid tumors.

Authors:  Hakan Ilaslan; Jean Schils; Michael Joyce; Kenneth Marks; Murali Sundaram
Journal:  Skeletal Radiol       Date:  2009-10-09       Impact factor: 2.199

10.  Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients.

Authors:  S Bonvalot; H Eldweny; V Haddad; F Rimareix; G Missenard; O Oberlin; D Vanel; P Terrier; J Y Blay; A Le Cesne; C Le Péchoux
Journal:  Eur J Surg Oncol       Date:  2007-08-20       Impact factor: 4.424

View more
  3 in total

Review 1.  Management of aggressive fibromatosis.

Authors:  Zhijun Zhang; Jian Shi; Tao Yang; Tongjun Liu; Kai Zhang
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

Review 2.  Multimodality Imaging Assessment of Desmoid Tumors: The Great Mime in the Era of Multidisciplinary Teams.

Authors:  Igino Simonetti; Federico Bruno; Roberta Fusco; Carmen Cutolo; Sergio Venanzio Setola; Renato Patrone; Carlo Masciocchi; Pierpaolo Palumbo; Francesco Arrigoni; Carmine Picone; Andrea Belli; Roberta Grassi; Francesca Grassi; Antonio Barile; Francesco Izzo; Antonella Petrillo; Vincenza Granata
Journal:  J Pers Med       Date:  2022-07-16

3.  The efficacy of low-power cumulative high-intensity focused ultrasound treatment for recurrent desmoid tumor.

Authors:  Xian Zhong; Xiaoye Hu; Peng Zhao; Yuebing Wang; Xue Feng Fang; Jiayi Shen; Hong Shen; Ying Yuan
Journal:  Cancer Med       Date:  2022-03-11       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.